SynthesisFrontiers in pharmacology2025

Comparative efficacy and safety of second-line therapies for patients with advanced hepatocellular carcinoma: a systematic review and network meta-analysis of randomized controlled trials.

Fengjiao Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.